A drug derived from ketamine will be added to the PBS, helping tens of thousands of Australians struggling with depression to ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A nasal spray that's having life-changing impacts on people living with depression is set to be listed on the PBS, slashing ...

A new drug for treatment-resistant depression will be listed on the Pharmaceutical Benefits Scheme this week, making it more ...

A new nasal spray that uses a form of ketamine to treat stubborn depression will be added to the PBS, making treatment ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...

A new nasal spray, that’s chemically similar to Ketamine, is being added to the Pharmaceutical Benefits Scheme, for adults ...

Follow the latest news headlines from Australia's most trusted source. Read in-depth expert analysis and watch live coverage on ABC News.

For the first time, the U.S. Food and Drug Administration (FDA) has approved the use of a ketamine-like drug as a stand-alone therapy for adults with treatment-resistant depression (TRD).

Yes—and no. Ketamine itself has been FDA-approved as an anesthetic for decades. However, its use in mental health is a more recent development. Specifically, a derivative known as esketamine ...

Mental health providers in Central Illinois offering ketamine say it has changed patients' lives for the better. Still, only ...

A groundbreaking nasal spray using a form of ketamine to treat stubborn depression is set to become more accessible and affordable for thousands of Australians. The spray, known as Spravato, will be ...